AI-Driven Drug Discovery Picks Up as FDA Pushes to Reduce Animal Testing

AI-Driven Drug Discovery Picks Up as FDA Pushes to Reduce Animal Testing

Within the next several years, using AI and cutting back on animal testing could reduce drug timelines and costs by at least half.

Psychedelic Researchers Respond to FDA’s Push to Reduce Animal Testing - Psychedelic Alpha

The FDA is pushing researchers to reduce their use of animal models and instead adopt ‘new approach methodologies’, like organoids and AI modelling. Researchers are divided: while some see this as a chance to innovate, many others are concerned it could compromise safety and disincentivise the use of established models. Here, Dr. Alaina Jaster speaks with psychedelic scientists and drug developers… Source

ESG News Recap: AI Used to Reduce Animal Testing for Drugs

Impakter Drug Developers to Reduce Animal Testing With AI Today’s ESG Updates AI to Replace Animal Testing in Drug Production: The U.S. FDA plans to phase out animal testing, with biotech firms adopting AI to cut drug development time in half European Socialists Reject Trump-EU Trade Deal: The European Parliament’s S&D group denounces the July agreement, warning it could enable Trump to escalate trade […] The post Drug Developers to Reduce Anima…

AI-driven drug discovery picks up as FDA pushes to reduce animal testing

Within the next three to five years, using AI and cutting back on animal testing could reduce timelines and costs by at least half